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Case Presentation:
Argyria Secondary to Systemic and Topical Absorption of Colloidal Silver Through
Natural Mineral Supplementation
Discussion:
Argyria is a well-documented condition due to chronic exposure to products that contain silver. It is characterized 
by slate-gray or blue dyspigmentation of the skin, conjunctiva, lunulae, hair, and oral mucosa. The most pronounced 
discoloration occurs in photodistributed areas. The differential diagnosis for argyria is large and includes cyanosis, 
Addison disease, Wilson disease, hemochromatosis, and methemoglobinemia. Histopathologically, argyria is characterized 
by multiple dark brown-black granules deposited in a band-like fashion in the basement membrane of the sweat glands. 
The granules are also found in elastic fibers in the papillary dermis, connective tissue sheaths around pilosebaceous 
follicles, in the arrector pili muscles, and in arterial walls. There is usually an increase in melanin pigment in the basal 
layer and increased melanophages in the papillary dermis. Extracellular clusters of granules deposited between collagen 
fibers have been demonstrated on electron microscopy.
Historically, silver has been used in medicine to treat mental illness, infections, and epilepsy as far back as the eighth 
century. It is still used today as a cauterizing agent, and an antimicrobial in the treatment of burns. Today the most likely 
cause of argyria is through ingestion of dietary supplements. Although the Food and Drug Administration banned the 
use of colloidal silver and silver salts in over-the-counter products in 1999, this ban did not apply to products that are 
marketed as dietary supplements. The advent of the internet in combination with its accessibility and lack of regulation 
allowed silver to be marketed as an “alternative health” aide and cure-all for the treatment of cancer, Lyme disease, HIV, 
arthritis, and Morgellon disease. 
It has been shown that at least six grams of silver ingested orally, or one gram of intravenous silver, is required to produce 
clinically apparent argyria. The mechanism by which the gray-blue cutaneous discoloration occurs is still up for debate. 
One theory suggests that it is the result of sunlight enhancing the direct stimulation of silver deposits on melanocytes 
to increase melanin production. Alternatively, some suggest sunlight acts as a catalyst for the reduction of silver within 
the dermis. Silver can also deposit into other organs such as the eyes, brain, spinal cord, stomach, liver, kidneys, 
adrenal glands, spleen, and testes. Adverse effects depend on the dose, duration, form, and route of exposure. Silver 
salts are more toxic than silver proteins and consumption of large doses can result in hemolysis, renal failure, pleural 
edema, seizures, and coma. Reports of physiologic derangement or organ damage are extremely rare in cases of tissue 
deposition. 
The discoloration of argyria may fade with time if ingestion is ceased, but rarely shows significant improvement. Chelation 
therapy with British anti-Lewsite (BAL) and D-pencillamine, intralesional therapy with sodium thiosulfate and potassium 
ferrocyanide, and topical therapy with hydroquinone and dermabrasion have all been tried with little to no success. 
Q-switched frequency doubled Nd-Yag laser  has been shown to be successful in a case report. It is important to always 
recommend sun avoidance and sunscreens to prevent further pigmentary change. 
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Patient: 69 year-old Caucasian female.
History of Present Illness: The patient presents 
with a six year history of skin dysesthesia and complaint of a 
substances extruding through the skin. She was noted to have 
a distinct blue-gray discoloration of the skin on her face and 
hands. She is self-medicating with an over-the-counter silver 
supplement called “NutraSilver.” The patient has been ingesting 
the liquid supplement and putting it in her eyes, nose, and ears 
intermittently for two years. She uses approximately 2-10 drops 
orally per day. 
Medical History/Surgical History: 
hypertension, hyperlipidemia, chronic headaches, 
cholecystectomy, coronary artery disease with coronary artery 
bypass graft and angioplasty
Social History: Retired office receptionist, married with 
children, denies current use or history of tobacco, alcohol, or illicit 
substances
Medications: NutraSilver micro-particle silver water 
(contains 3600 PPM colloidal silver), amlodipine, propranolol/
hydrochlorothiazide, atorvastatin, aspirin, amitriptyline, probiotic 
supplement
Physical Examination: Examination reveals slate-
gray to blue discoloration of the skin most prominent on the 
forehead, cheeks, and nose with sparing of the periorbital and 
perinasal skin (Figure 1). The conjunctiva and oral mucosa appear 
normal in color. The bilateral dorsa of the hands are also blue-gray 
discolored and lanulae have a faint blue hue (Figure 2). Her hair 
does not have a silver tinge. 
Laboratory Data: BPAg 180, CBC, and CMP were all 
WNL or negative.
Biopsy: Advanced Dermatology Associates, LTD (AD15-
15604, 12/30/2015) Left lateral forehead: “Silver deposition 
(Argyria)- Microscopic brown-black granules stipple the basement 
Figure 1: Clinical image of patient’s face 
demonstrating the gray-blue discoloration.
Figure 2: Clinical image of patient’s hands 
demonstrating the faint blue lunulae.
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Figure 3: Biopsy from the left lateral forehead: 
Silver Deposition (Argyria)- Microscopic brown-
black granules stipple the basement membrane 
of sweat glands (Arrows). 
